In vivo evidence for functional NMDA receptor blockade by memantine in rat hippocampal neurons

Journal of Neural Transmission

Volumn 117, Issue 10, 2010, Pages 1189-1194

  Szegedi, Viktor ^d   Juhász, Gábor ^a   Parsons, Chris G ^b   Budai, Dénes ^c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

^c Kation Europe Bt   (Hungary)

^d NONE

Author keywords

Alzheimer's disease; Antagonist; NMDA receptor; Single unit

Indexed keywords

MAGNESIUM; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CA1 REGION, HIPPOCAMPAL; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MALE; MEMANTINE; NEURONS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 78651227926     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0471-y     Document Type: Article

References (33)

1. TA Blanpied FA Boeckman E Aizenman JW Johnson 1997 Trapping channel block of NMDA-activated responses by amantadine and memantine J Neurophysiol 77 309 323 1:CAS:528:DyaK2sXhtlWlt7s%3D 9120573
2. D. Budai (2010) Carbon Fiber-based microelectrodes and microbiosensors, intelligent and biosensors. In: V.S. Somerset (ed) Intelligent and biosensors, INTECH
3. HS Chen SA Lipton 2005 Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-d-aspartate-gated channels J Pharmacol Exp Ther 314 961 971 1:CAS:528:DC%2BD2MXpvFSru7g%3D 10.1124/jpet.105.085142 15901795 (Pubitemid 41205958)
4. Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004 re16
5. W Danysz CG Parsons 2002 Neuroprotective potential of ionotropic glutamate receptor antagonists Neurotox Res 4 119 126 1:CAS:528: DC%2BD38XmvFShtb4%3D 10.1080/10298420290015872 12829411 (Pubitemid 34285054)
6. HN David M Ansseau M Lemaire JH Abraini 2006 Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization Biol Psychiatry 60 49 57 1:CAS:528:DC%2BD28XmtVOitb4%3D 10.1016/j.biopsych.2005.10. 007 16427030
7. R Dingledine K Borges D Bowie SF Traynelis 1999 The glutamate receptor ion channels Pharmacol Rev 51 7 61 1:CAS:528:DyaK1MXitFWgurs%3D 10049997
8. GE Hardingham Y Fukunaga H Bading 2002 Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways Nat Neurosci 5 405 414 1:CAS:528:DC%2BD38XjtFykurw%3D 11953750
9. JF Herrero PM Headley CG Parsons 1994 Memantine selectively depresses NMDA receptor-mediated responses of ratspinal neurones in vivo Neurosci Lett 165 37 40 1:CAS:528:DyaK2cXis1WjtL4%3D 10.1016/0304-3940(94)90703-X 7517024 (Pubitemid 24043234)
10. NW Hu I Klyubin R Anwy MJ Rowan 2009 GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo Proc Natl Acad Sci USA 106 20504 20509 1:CAS:528:DC%2BC3cXjtFWhsA%3D%3D 10.1073/pnas.0908083106 19918059
11. MW Jones M McClean CG Parsons PM Headley 2001 The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones Neuropharmacology 41 50 61 1:CAS:528:DC%2BD3MXltVaks74%3D 10.1016/S0028-3908(01)00041-7 11445185 (Pubitemid 32607644)
12. K Kashiwagi T Masuko CD Nguyen T Kuno I Tanaka K Igarashi K Williams 2002 Channel blockers acting at N-methyl-d-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore Mol Pharmacol 61 533 545 1:CAS:528:DC%2BD38XitVSmtbs%3D 10.1124/mol.61.3.533 11854433 (Pubitemid 34171919)
13. J Kornhuber EM Kennepohl S Bleich J Wiltfang T Kraus U Reulbach I Meineke 2007 Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach Clin Pharmacokinet 46 599 612 1:CAS:528: DC%2BD2sXptlGru78%3D 10.2165/00003088-200746070-00005 17596105 (Pubitemid 47025360)
14. 2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine J Neurosci 29 2774 2779 1:CAS:528:DC%2BD1MXjt1Wmurc%3D 10.1523/JNEUROSCI.3703-08.2009 19261873
15. 2+ block in NMDA receptor channels J Neurosci 16 3549 3558 1:CAS:528:DyaK28XjtF2nu74%3D 8642401
16. T Kutsuwada N Kashiwabuchi H Mori K Sakimura E Kushiya K Araki H Meguro H Masaki T Kumanishi M Arakawa, et al. 1992 Molecular diversity of the NMDA receptor channel Nature 358 36 41 1:CAS:528:DyaK38Xks1elsrg%3D 10.1038/358036a0 1377365
17. SA Lipton 2006 Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond Nat Rev 5 160 170 1:CAS:528:DC%2BD28Xhslaquro%3D
18. C McFarlane DS Warner F Dexter 1995 Interactions between NMDA and AMPA glutamate receptor antagonists during halothane anesthesia in the rat Neuropharmacology 34 659 663 1:CAS:528:DyaK2MXmvFygu7w%3D 10.1016/0028-3908(95) 00029-6 7566502
19. B Meldrum J Garthwaite 1990 Excitatory amino acid neurotoxicity and neurodegenerative disease Trends Pharmacol Sci 11 379 387 1:CAS:528: DyaK3cXlvVCrsrk%3D 10.1016/0165-6147(90)90184-A 2238094 (Pubitemid 20262465)
20. H Monyer N Burnashev DJ Laurie B Sakmann PH Seeburg 1994 Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 529 540 1:CAS:528:DyaK2cXitlKku7w%3D 10.1016/0896-6273(94) 90210-0 7512349 (Pubitemid 24100885)
21. L More A Gravius J Nagel B Valastro S Greco W Danysz 2008 Therapeutically relevant plasma concentrations of memantine produce significant l-N-methyl-d-aspartate receptor occupation and do not impair learning in rats Behavioural pharmacol 19 724 734 1:CAS:528:DC%2BD1cXhtFajurvM 10.1097/FBP.0b013e3283123cad
22. CG Parsons K Gilling 2007 Memantine as an example of a fast, voltage-dependent, open channel N-methyl-d-aspartate receptor blocker Methods Mol Biol 403 15 36 1:CAS:528:DC%2BD2sXht1Wnsr%2FM 10.1007/978-1-59745-529-9-2 18827985
23. CG Parsons W Danysz A Bartmann P Spielmanns T Frankiewicz M Hesselink B Eilbacher G Quack 1999 Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization Neuropharmacology 38 85 108 1:CAS:528:DyaK1MXhsF2htr0%3D 10.1016/S0028-3908(98)00161-0 10193901 (Pubitemid 29073529)
24. CG Parsons A Stoffler W Danysz 2007 Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse Neuropharmacology 53 699 723 1:CAS:528:DC%2BD2sXhtFGrsLzF 10.1016/j.neuropharm.2007.07.013 17904591 (Pubitemid 47532143)
25. W Qiu R Wei C Zhang C Zhang W Leng W Wang 2010 A glycine site-specific NMDA receptor antagonist protects retina ganglion cells from ischemic injury by modulating apoptotic cascades J Cell Physiol 223 819 826 1:CAS:528: DC%2BC3cXktFyqt7w%3D 20333677
26. MA Rogawski GL Wenk 2003 The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease CNS Drug Rev 9 275 308 1:CAS:528:DC%2BD3sXoslyjsLY%3D 10.1111/j.1527-3458.2003.tb00254.x 14530799
27. T Sanelli W Ge C Leystra-Lantz MJ Strong 2007 Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant J Neurol Sci 256 39 51 1:CAS:528:DC%2BD2sXktF2ku7s%3D 10.1016/j.jns.2007.02.018 17368487 (Pubitemid 46560625)
28. HP Schmitt 2005 On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease Med Hypotheses 65 259 265 1:CAS:528:DC%2BD2MXks1Gnsbc%3D 10.1016/j.mehy.2005.03.011 15922097 (Pubitemid 40744751)
29. GM Shankar BL Bloodgood M Townsend DM Walsh DJ Selkoe BL Sabatini 2007 Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway J Neurosci 27 2866 2875 1:CAS:528:DC%2BD2sXjs1Wqu7o%3D 10.1523/JNEUROSCI.4970-06.2007 17360908 (Pubitemid 46438992)
30. J Shehadeh HB Fernandes MM Zeron Mullins RK Graham BR Leavitt MR Hayden LA Raymond 2006 Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease Neurobiol Dis 21 392 403 1:CAS:528:DC%2BD28XmsVGnuw%3D%3D 10.1016/j.nbd.2005.08. 001 16165367 (Pubitemid 43099862)
31. S Sombati RJ Delorenzo 1995 Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture J Neurophysiol 73 1706 1711 1:STN:280:DyaK2MzntVyqtA%3D%3D 7643176
32. CJ Woolf MS Chong 1993 Preemptive analgesia - treating postoperative pain by preventing the establishment of central sensitization Anesth Analg 77 362 379 1:STN:280:DyaK3szkvV2lsA%3D%3D 8346839
33. GC Yeh DW Bonhaus JV Nadler JO McNamara 1989 N-methyl-d-aspartate receptor plasticity in kindling: quantitative and qualitative alterations in the N-methyl-d-aspartate receptor-channel complex Proc Natl Acad Sci USA 86 8157 8160 1:CAS:528:DyaL1MXmt1GkurY%3D 10.1073/pnas.86.20.8157 2479019